Anil Jindal

SRS Health, the business vertical of SRS Group, plans to open around 25-30 outlets to start off with, in the next 3-4 months, in the Delhi-NCR region. The medicine stores would be opened under the 'SRS Pharmacy' brand.

Sebi objective on new delisting norms unclear: Anil Jindal

Anil Jindal, a market expert who has been tracking delisting norms for over a decade, says the objective of Sebi is unclear – is Sebi doing this for the shareholders, or is the objective not to allow companies to delist?

SRS Real Infrastructure eyes Rs 1,200-cr revenue in FY14

The company had clocked a turnover of Rs 851 crore in 2012-13, registering over 17 percent growth in FY 2012.

SRS Group chairman throws a wedding fit for royalty

Larger than life celebrations and luxury flowed unapologetically in the wedding of SRS Group Chairman Anil Jindal‘s daughter as he left no stone unturned in putting together a show fit for royalty.

BTL Investments buys 20 lakh shares of SRS Real Infra

On May 8, 2012 BTL Investments And Securities Ltd bought 2,000,000 shares at Rs 34.30.

SRS plunges 30% on debut

Shares of SRS, a company into business from cinema exhibition, jewellery, food to retail, slipped sharply in the opening trade on listing day. The stock was trading near day's low of Rs 40.40, down 30.34% from issue price of Rs 68 a share on the National Stock Exchange.

SRS eyes revenue of Rs 3000cr for FY12, sees PAT at Rs 80cr

Diversified group SRS is planning to expand its four verticals such as cinema, food courts, retail stores and jewellery stores. Anil Jindal, chairman of SRS, in an interview to CNBC-TV18, spoke about the latest happenings in the company and gave his views on how the company is going to perform in the future.

Jewellery business margins to improve from current 6%: SRS

Diversified group SRS is looking to expand in all four verticals (cinema, food courts, retail stores and jewellery stores) of its business with the IPO proceeds.